Product image of Glusod (Empagliflozin) supplied by GNH India

Glusod

Active Ingredient:
Empagliflozin
Origin:
EU

Glusod (Empagliflozin)

Glusod is a prescription medication that contains the active ingredient empagliflozin, an SGLT2 inhibitor administered orally for the treatment of type 2 diabetes mellitus. Marketed in the European Union, Glusod reduces renal glucose reabsorption, increasing urinary glucose excretion. The tablet’s dosage strength is determined by the prescribing physician, and it is intended for patients following medical guidance and should be used as part of a comprehensive diabetes management plan.

Manufacturer / TM Owner

Medochemie Hellas Sa

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Glusod is indicated for the management of hyperglycemia in adults with type 2 diabetes mellitus, typically as an adjunct to diet and exercise.

  • As monotherapy when metformin is not tolerated.
  • In combination with metformin to improve glycemic control.
  • Added to insulin therapy to reduce insulin dose requirements.
  • Used in patients with established cardiovascular risk to provide renal and cardiovascular benefits.
  • May be considered when additional oral agents are needed to achieve target HbA1c.

Side Effects

The safety profile of Glusod reflects the pharmacology of empagliflozin and includes both frequent, mild events and less common, serious reactions.

Common

  • Increased urinary frequency.
  • Genital mycotic infections such as candidiasis.
  • Thirst or dry mouth.
  • Mild hypotension, especially in the elderly or those on diuretics.

Serious

  • Euglycemic diabetic ketoacidosis.
  • Acute kidney injury.
  • Severe dehydration.
  • Fournier's gangrene (necrotizing fasciitis of the perineum).

Precautions & Warnings

Before initiating Glusod, healthcare providers should evaluate several clinical factors to minimize risk.

  • Assess renal function; avoid use in severe renal impairment.
  • Monitor for signs of hypotension, particularly in patients on antihypertensives.
  • Evaluate risk of genital infections; counsel on hygiene.
  • Review history of ketoacidosis; discontinue if metabolic acidosis occurs.
  • Ensure adequate hydration to reduce dehydration risk.
  • Use caution in elderly patients due to orthostatic effects.

Avoid Interactions

Glusod may interact with other medicines, influencing its efficacy or safety.

Avoid

  • Concomitant use with other SGLT2 inhibitors (duplicate therapy).
  • Strong diuretics that may exacerbate dehydration.
  • Medications that cause significant hypoglycemia (e.g., insulin, sulfonylureas) without dose adjustment.

Use with caution

  • Loop diuretics – monitor volume status.
  • ACE inhibitors or ARBs – watch renal function and potassium levels.
  • Antihypertensive agents – observe blood pressure.
  • Rifampin – may reduce empagliflozin plasma concentrations.

Frequently Asked Questions

Glusod is a brand name for the drug empagliflozin, an oral SGLT2 inhibitor that blocks sodium‑glucose co‑transporter 2 in the kidneys, reducing glucose reabsorption and increasing its excretion in urine, which helps lower blood sugar levels.

Glusod is prescribed for adult patients with type 2 diabetes mellitus who need additional glycemic control beyond diet, exercise, and other antidiabetic agents, provided they have adequate renal function and no contraindicating conditions.

Glusod is taken orally, usually once daily, with or without food. Patients should follow the dosing schedule advised by their healthcare professional.

Common side effects include increased urinary frequency, genital yeast infections, thirst, dry mouth, and mild drops in blood pressure, especially in older adults or those taking diuretics.

When combined with insulin or insulin‑secretagogues, Glusod can increase the risk of hypoglycemia. Dose adjustments of the other agents may be necessary, and blood glucose should be monitored closely.

Routine monitoring includes blood glucose levels, renal function (eGFR), electrolytes, blood pressure, and assessment for signs of genital infections or ketoacidosis.

Glusod should be avoided in patients with severe renal impairment. In mild to moderate kidney dysfunction, dose adjustment and close monitoring are recommended.

Empagliflozin, the active ingredient in Glusod, has demonstrated cardiovascular benefits in clinical studies, including reduced risk of cardiovascular death and hospitalization for heart failure in patients with type 2 diabetes.

Patients should inform their healthcare provider promptly. Treatment may involve topical or oral antifungal medication, and temporary discontinuation of Glusod may be considered based on clinical judgment.

Alcohol can increase the risk of dehydration and low blood sugar, especially when combined with antidiabetic medications. Moderate consumption is advised, and patients should discuss alcohol use with their clinician.

There are no specific dietary restrictions, but patients should maintain a balanced diet, stay hydrated, and follow any nutritional guidance provided by their diabetes care team.

Glycemic improvement is typically observed within a few weeks of starting therapy, but individual response varies. Ongoing monitoring helps determine effectiveness and need for dose adjustments.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Empagliflozin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT